• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多种疾病并存的代谢组学:它会是吗?

Metabolomics of Multimorbidity: Could It Be the ?

作者信息

Dash Pujarini, Mohapatra Soumya R, Pati Sanghamitra

机构信息

Regional Medical Research Centre, Bhubaneswar, India.

Department of Research and Development, Kalinga Institute of Medical Sciences, KIIT Deemed to Be University, Bhubaneswar, India.

出版信息

Front Mol Biosci. 2022 Mar 11;9:848971. doi: 10.3389/fmolb.2022.848971. eCollection 2022.

DOI:10.3389/fmolb.2022.848971
PMID:35359598
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8962190/
Abstract

Multimorbidity, the simultaneous presence of two or more chronic diseases, affects the health care to a great extent. Its association with health care cost, more disability, and poor quality of life makes it a major public health risk. The matter of worry is that management of a multimorbid condition is complicated by the fact that multiple types of treatment may be required to treat different diseases at a time, and the interaction between some of the therapies can be detrimental. Understanding the causal factors of simultaneously occurring disease conditions and investigating the connected pathways involved in the whole process may resolve the complication. When different disease conditions present in an individual share common responsible factors, treatment strategies targeting at those common causes will certainly reduce the chance of development of multimorbidity occurring because of those factors. Metabolomics that can dig out the underlying metabolites/molecules of a medical condition is believed to be an effective technique for identification of biomarkers and intervention of effective treatment strategies for multiple diseases. We hypothesize that understanding the metabolic profile may shed light on targeting the common culprit for different/similar chronic diseases ultimately making the treatment strategy more effective with a combinatorial effect.

摘要

多重疾病,即同时存在两种或更多慢性疾病,在很大程度上影响着医疗保健。它与医疗费用增加、更多残疾以及生活质量差相关联,使其成为一个重大的公共卫生风险。令人担忧的是,多重疾病状态的管理很复杂,因为可能需要同时采用多种类型的治疗来治疗不同疾病,而且某些治疗之间的相互作用可能是有害的。了解同时发生的疾病状况的因果因素并研究整个过程中涉及的相关途径可能会解决这一复杂性。当个体中不同的疾病状况有共同的责任因素时,针对这些共同原因的治疗策略肯定会降低因这些因素而发生多重疾病的几率。代谢组学能够挖掘出疾病潜在的代谢物/分子,被认为是一种识别生物标志物以及干预多种疾病有效治疗策略的有效技术。我们假设,了解代谢谱可能有助于针对不同/相似慢性疾病的共同罪魁祸首进行靶向治疗,最终使治疗策略通过联合效应更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5639/8962190/92493d5689e9/fmolb-09-848971-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5639/8962190/5932a03327b9/fmolb-09-848971-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5639/8962190/92493d5689e9/fmolb-09-848971-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5639/8962190/5932a03327b9/fmolb-09-848971-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5639/8962190/92493d5689e9/fmolb-09-848971-g002.jpg

相似文献

1
Metabolomics of Multimorbidity: Could It Be the ?多种疾病并存的代谢组学:它会是吗?
Front Mol Biosci. 2022 Mar 11;9:848971. doi: 10.3389/fmolb.2022.848971. eCollection 2022.
2
Estimating and characterizing the burden of multimorbidity in the community: A comprehensive multistep analysis of two large nationwide representative surveys in France.估算和描述社区中多种疾病负担:法国两项全国代表性大型调查的综合多步骤分析。
PLoS Med. 2021 Apr 26;18(4):e1003584. doi: 10.1371/journal.pmed.1003584. eCollection 2021 Apr.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Improving medication management in multimorbidity: development of the MultimorbiditY COllaborative Medication Review And DEcision Making (MY COMRADE) intervention using the Behaviour Change Wheel.改善多重疾病状态下的药物管理:运用行为改变轮开发多重疾病协作药物审查与决策制定(MY COMRADE)干预措施
Implement Sci. 2015 Sep 24;10:132. doi: 10.1186/s13012-015-0322-1.
5
Multimorbidity, health care utilization and costs in an elderly community-dwelling population: a claims data based observational study.老年社区居住人群的多重疾病、医疗保健利用及费用:一项基于索赔数据的观察性研究。
BMC Health Serv Res. 2015 Jan 22;15:23. doi: 10.1186/s12913-015-0698-2.
6
Multimorbidity epidemiology and health care utilization through combined healthcare administrative databases.多病共存的流行病学和通过联合医疗保健管理数据库的医疗保健利用。
Epidemiol Prev. 2021 Jan-Apr;45(1-2):62-71. doi: 10.19191/EP21.1-2.P062.040.
7
Guideline deviation and its association with specific chronic diseases among patients with multimorbidity: a cross-sectional cohort study in a care management setting.多病共存患者的指南偏离及其与特定慢性病的关系:在照护管理环境中进行的一项横断面队列研究。
BMJ Open. 2021 Jan 11;11(1):e040961. doi: 10.1136/bmjopen-2020-040961.
8
Movement through Active Personalised engagement (MAP) - a self-management programme designed to promote physical activity in people with multimorbidity: study protocol for a randomised controlled trial.通过积极个性化参与实现运动(MAP)——一项旨在促进患有多种疾病的人群进行体育活动的自我管理计划:一项随机对照试验的研究方案
Trials. 2018 Oct 20;19(1):576. doi: 10.1186/s13063-018-2939-2.
9
Use of latent class analysis to identify multimorbidity patterns and associated factors in Korean adults aged 50 years and older.利用潜在类别分析识别 50 岁及以上韩国成年人的多种共病模式及其相关因素。
PLoS One. 2019 Nov 13;14(11):e0216259. doi: 10.1371/journal.pone.0216259. eCollection 2019.
10
Aging with multimorbidity: a systematic review of the literature.患有多种慢性病的老龄化:文献系统综述。
Ageing Res Rev. 2011 Sep;10(4):430-9. doi: 10.1016/j.arr.2011.03.003. Epub 2011 Mar 23.

引用本文的文献

1
Metabolite and protein associations with general health in the population-based CHRIS study.基于人群的 CHRIS 研究中代谢物和蛋白质与整体健康的关联。
Sci Rep. 2024 Nov 4;14(1):26635. doi: 10.1038/s41598-024-75627-3.
2
Neonatal multimorbidity and the phenotype of premature aging in preterm infants.新生儿多种疾病并存与早产儿早衰表型
Pediatr Res. 2024 Oct 25. doi: 10.1038/s41390-024-03617-2.
3
The performance of metabolomics-based prediction scores for mortality in older patients with solid tumors.基于代谢组学的预测评分对老年实体瘤患者死亡率的预测性能。

本文引用的文献

1
Identifying longitudinal clusters of multimorbidity in an urban setting: A population-based cross-sectional study.在城市环境中识别多重疾病的纵向聚类:一项基于人群的横断面研究。
Lancet Reg Health Eur. 2021 Mar 2;3:100047. doi: 10.1016/j.lanepe.2021.100047. eCollection 2021 Apr.
2
Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities.代谢与慢性炎症:慢性心力衰竭与合并症之间的联系
Front Cardiovasc Med. 2021 May 5;8:650278. doi: 10.3389/fcvm.2021.650278. eCollection 2021.
3
Multimorbidity and Its Outcomes Among Patients Attending Psychiatric Care Settings: An Observational Study From Odisha, India.
Geroscience. 2024 Dec;46(6):5615-5627. doi: 10.1007/s11357-024-01261-6. Epub 2024 Jul 4.
精神卫生保健机构就诊患者的多病共存及其结局:来自印度奥里萨邦的一项观察性研究。
Front Public Health. 2021 Apr 21;8:616480. doi: 10.3389/fpubh.2020.616480. eCollection 2020.
4
Plasma metabolites to profile pathways in noncommunicable disease multimorbidity.用于描绘非传染性疾病多种疾病相关途径的血浆代谢产物。
Nat Med. 2021 Mar;27(3):471-479. doi: 10.1038/s41591-021-01266-0. Epub 2021 Mar 11.
5
Managing Multimorbidity (Multiple Chronic Diseases) Amid COVID-19 Pandemic: A Community Based Study From Odisha, India.管理 COVID-19 大流行期间的多种合并症(多种慢性病):来自印度奥里萨邦的一项社区研究。
Front Public Health. 2021 Feb 1;8:584408. doi: 10.3389/fpubh.2020.584408. eCollection 2020.
6
Multimorbidity patterns among COVID-19 deaths: proposal for the construction of etiological models.新冠疫情死亡病例中的共病模式:病因模型构建建议
Rev Panam Salud Publica. 2020 Dec 30;44:e166. doi: 10.26633/RPSP.2020.166. eCollection 2020.
7
The therapeutic potential of targeting tryptophan catabolism in cancer.靶向色氨酸分解代谢治疗癌症的潜力。
Br J Cancer. 2020 Jan;122(1):30-44. doi: 10.1038/s41416-019-0664-6. Epub 2019 Dec 10.
8
Health related quality of life in multimorbidity: a primary-care based study from Odisha, India.多病症患者的健康相关生活质量:来自印度奥里萨邦的一项基于初级保健的研究。
Health Qual Life Outcomes. 2019 Jul 5;17(1):116. doi: 10.1186/s12955-019-1180-3.
9
Secondary Bile Acids and Short Chain Fatty Acids in the Colon: A Focus on Colonic Microbiome, Cell Proliferation, Inflammation, and Cancer.次级胆酸和结肠中的短链脂肪酸:关注结肠微生物组、细胞增殖、炎症和癌症。
Int J Mol Sci. 2019 Mar 11;20(5):1214. doi: 10.3390/ijms20051214.
10
Comparison of Comorbid Conditions Between Cancer Survivors and Age-Matched Patients Without Cancer.癌症幸存者与年龄匹配的非癌症患者共病情况的比较。
J Clin Med Res. 2018 Dec;10(12):911-919. doi: 10.14740/jocmr3617w. Epub 2018 Oct 30.